(1)
Parmar, A.; Timilshina, N.; Emmenegger, U.; Smoragiewicz, M.; Sander, B.; Alibhai, S. .; Chan, K. K. A Cost-Utility Analysis of Apalutamide for Metastatic Castrationsensitive Prostate Cancer. CUAJ 2021, 16, E126-31.